Na. Zhang, et.al., The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism., Cell metabolism, 2010, 11

http://rdf.ncbi.nlm.nih.gov/pubmed/20399150

Na. Zhang, et.al., The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism., Cell metabolism, 2010, 11

http://rdf.ncbi.nlm.nih.gov/pubmed/

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD18116
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD18116
• CD00846
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD00846
• CD07465
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD07465
• CD05717
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD05717
• CD10862
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD10862

allele

http://purl.org/net/cito/citesAsAuthority

• Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4459899
• Hif1an<tm1.1Rsjo>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4459908

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased heart rate_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0002626B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• decreased circulating VLDL triglyceride level_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0003976B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• decreased circulating triglyceride level_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0002644B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• increased basal metabolism_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0008965B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• decreased quadriceps weight_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0010227B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• decreased white fat cell size_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0009133B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• increased carbon dioxide production_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0008963B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• abnormal lung volume_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0001942B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• decreased circulating HDL cholesterol level_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0000186B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• increased tidal volume_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0005585B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• decreased circulating cholesterol level_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0005179B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• increased oxygen consumption_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0005289B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• decreased circulating insulin level_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0002727B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• abnormal oxygen level_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0001574B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• decreased susceptibility to weight gain_Hif1an<tm1.1Rsjo>/Hif1an<tm1.1Rsjo>,Tg(Nes-cre)1Wme/0
  http://metadb.riken.jp/0010182I129C57BL6CBAHif1antm11RsjoHif1antm11RsjoTgNescre1Wme0Hif1antm11RsjoTgNescre1Wme
• decreased circulating insulin level_Hif1an<tm1.1Rsjo>/Hif1an<tm1.1Rsjo>,Tg(Nes-cre)1Wme/0
  http://metadb.riken.jp/0002727I129C57BL6CBAHif1antm11RsjoHif1antm11RsjoTgNescre1Wme0Hif1antm11RsjoTgNescre1Wme
• increased food intake_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0011939B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• decreased epididymal fat pad weight_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0009289B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• decreased cell proliferation_Hif1a<tm1Rsjo>/Hif1a<tm1Rsjo>,Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0000352I129S1Sv129X1SvJHif1atm1RsjoHif1atm1RsjoHif1antm12RsjoHif1antm12RsjoHif1atm1RsjoHif1antm12Rsjo
• increased fluid intake_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0011941B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• hypocapnia_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0003032B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• increased pulmonary respiratory rate_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0005573B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• decreased susceptibility to hepatic steatosis_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0002310B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• hypoactivity_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0001402B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• alkalosis_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0003028B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• increased insulin sensitivity_Hif1an<tm1.1Rsjo>/Hif1an<tm1.1Rsjo>,Tg(Nes-cre)1Wme/0
  http://metadb.riken.jp/0002891I129C57BL6CBAHif1antm11RsjoHif1antm11RsjoTgNescre1Wme0Hif1antm11RsjoTgNescre1Wme
• no abnormal phenotype detected_Hif1an<tm1.1Rsjo>/Hif1an<tm1.1Rsjo>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0002169I129C57BL6DBAHif1antm11RsjoHif1antm11RsjoTgAlbcre21Mgn0Hif1antm11RsjoTgAlbcre21Mgn
• decreased cell proliferation_Vhl<tm1Jae>/Vhl<tm1Jae>
  http://metadb.riken.jp/0000352I129S4SvJaeVhltm1JaeVhltm1JaeVhltm1Jae
• decreased circulating glucose level_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0005560B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• abnormal circulating hormone level_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0005418B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• decreased circulating LDL cholesterol level_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0000183B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• abnormal cell physiology_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0005621B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• increased insulin sensitivity_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0002891B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• decreased susceptibility to weight gain_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0010182B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• increased circulating cholesterol level_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0005178B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• decreased liver weight_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0003402B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• decreased body weight_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0001262B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo
• decreased liver triglyceride level_Hif1an<tm1.2Rsjo>/Hif1an<tm1.2Rsjo>
  http://metadb.riken.jp/0009356B6129Hif1antm12RsjoHif1antm12RsjoHif1antm12RsjoHif1antm12Rsjo